Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.120.2.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.120.2.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.120.2.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.416.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.416.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.416.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.532NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.532NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.532NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.408NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.408NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.408NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XHNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XHNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.407NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.407NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.407NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.423NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.423NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.423NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.281NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.281NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.281NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.230NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.230NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.230NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.535NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.535NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.535NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used